Supernus Pharmaceuticals | Crediti Commerciali

Prezzo Delle Azioni
51.23
Cambio Giornaliero
1.86 3.77%
Mensile
-0.02%
Annuale
33.41%
Q1 Previsione
46.68




Crediti Commerciali Cambiamento Data
Abbott USD 10.4B 166M 2025-09
ANI Pharmaceuticals USD 252.62M 26.96M 2025-09
Aurora Cannabis CAD 46.73M 7.59M 2025-09
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Canopy Growth CAD 26.86M 23.17M 2025-09
Corcept Therapeutics USD 69.63M 5.06M 2025-09
Eisai JPY 224.06B 4.08B 2025-09
Eli Lilly USD 19.46B 2.25B 2025-09
Novo Nordisk DKK 95.05B 2.4B 2025-12
Pacira USD 115.27M 901K 2025-09
Perrigo USD 644.4M 62.2M 2025-09
Pfizer USD 18.12B 2.02B 2025-09
Supernus Pharmaceuticals USD 171.25M 30.42M 2025-09
United Therapeutics USD 297.7M 81.6M 2025-09
Xeris Pharmaceuticals USD 53.75M 700K 2025-09


Supernus Pharmaceuticals Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.